๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

THE ROLE OF EXTERNAL EVIDENCE IN DATA MONITORING OF A CLINICAL TRIAL

โœ Scribed by STUART J. POCOCK


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
684 KB
Volume
15
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

โœฆ Synopsis


Data monitoring of interim results from a randomized clinical trial should take into consideration evidence from other trials. This article presents both scientific and practical issues regarding the pros and cons of formally incorporating such external evidence into the decision making process for the current trial. Guidelines on how to use other trials' data are presented, along with cautiously sceptical comments on the impracticality of using formal meta-analyses in data monitoring. The arguments are illustrated by recent examples from specific trials, and the article concludes with some general recommendations.


๐Ÿ“œ SIMILAR VOLUMES


THE ROLE OF META-ANALYSIS IN MONITORING
โœ COLIN B. BEGG ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 665 KB

The randomized clinical trial is the gold standard methodology for evaluating treatment interventions. The randomized trial is a prospective experimental study, the embodiment of the scientific method applied to the clinic. Both organizational and ethical considerations encourage the use of formal c

META-ANALYSIS IN THE DESIGN AND MONITORI
โœ REBECCA DERSIMONIAN ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 828 KB

Results from external studies often play an important role in many aspects of a clinical trial. Their incorporation into the decision making process of a trial, however, is rarely conducted in a formal manner. This conference will address what formal role, if any, meta-analytic summaries of external

Cancer clinical trial recruitment : The
โœ Martin Tattersall ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 46 KB ๐Ÿ‘ 1 views

Clinical Research Associates have assumed an expanding role in the conduct and design of clinical trial protocols. The perspectives of these health professionals are presented in the referenced articles, and implications for clinical trials are discussed. See also pages 1577โ€“83 and 1584โ€“91.

ROLE OF META-ANALYSES IN DESIGN AND MONI
โœ NANCY L. GELLER ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 253 KB ๐Ÿ‘ 2 views

was followed by discussion which often required intervention by the moderator, Bill Brown. DerSimonian introduced the topic with an example of a meta-analysis of several trials on calcium supplementation for the prevention of pre-eclampsia. Discussing the wide differences in study design and qualit

Outcome assessment in clinical trials ev
โœ Robert F. Meenan; Jennifer J. Anderson; Lewis E. Kazis; Marlene J. Egger; Mary A ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 828 KB

Health status measures are conceptually relevant to the assessment of clinical outcome in the rheumatic diseases, but their ability to detect meaningful changes in health has not been clearly demonstrated. This report describes the performance of a self-administered health status questionnaire in a